Live Breaking News & Updates on Engager Therapeutics

Stay updated with breaking news from Engager therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Innate Pharma SA: Innate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update

Innate Pharma SA: Innate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Henry Wheeler , Zwei Rohstoff Chancen , Arthur Rouill , Experte Carsten Stork , Sonia Quaratino , Company Annual Report On Form , French Financial Markets Authority , Exchange Commission , Regulatory News , Euronext Paris , Chief Executive Officer , Executive Vice President , Chief Medical Officer , Chief Operating Officer , Senior Vice President , Chief Financial Officer , Innate Pharma , Engager Therapeutics , Private Securities Litigation Reform Act , Risk Factors , Universal Registration Document , Annual Report ,

Innate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update

07.05.2024 - Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Tuesday, May 14, 2024, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business . ....

Sonia Quaratino , Exchange Commission , French Financial Markets Authority , Company Annual Report On Form , Chief Executive Officer , Executive Vice President , Chief Medical Officer , Chief Operating Officer , Senior Vice President , Chief Financial Officer , Innate Pharma , Engager Therapeutics , Euronext Paris , Private Securities Litigation Reform Act , Risk Factors , Universal Registration Document , French Financial , Markets Authority , Annual Report , Innate Pharma Aktie , Nnate Pharma Spons Ads Aktie ,

Innate Pharma SA: Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate

Innate Pharma SA: Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Eric Vivier , Henry Wheeler , Dennis Riedl , Arthur Rouill , American Association For Cancer Research , Company Annual Report On Form , Exchange Commission , French Financial Markets Authority , Antibody Drug Conjugate , Euronext Paris , American Association , Cancer Research , Annual Meeting , Enfortumab Vedotin , Chief Scientific Officer , Innate Pharma , Engager Therapeutics , Private Securities Litigation Reform Act , Risk Factors , Universal Registration Document , Annual Report ,

Innate Pharma SA: Innate Pharma Announces Its Participation in Upcoming Investor Conference

Innate Pharma SA: Innate Pharma Announces Its Participation in Upcoming Investor Conference
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Noord Holland , Van Lanschot Kempen , Dennis Riedl , Arthur Rouill , Henry Wheeler , French Financial Markets Authority , Exchange Commission , Company Annual Report On Form , Regulatory News , Euronext Paris , Lanschot Kempen , Engager Therapeutics , Innate Pharma , Private Securities Litigation Reform Act , Risk Factors , Universal Registration Document , Annual Report ,